Literature DB >> 32601385

Economic value of exome sequencing for suspected monogenic disorders.

Bart S Ferket1, David L Veenstra2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32601385     DOI： 10.1038/s41436-020-0888-0

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  5 in total

Review 1.  An emerging field of research: challenges in pediatric decision making.

Authors:  Ellen A Lipstein; William B Brinkman; Alexander G Fiks; Kristin S Hendrix; Jennifer Kryworuchko; Victoria A Miller; Lisa A Prosser; Wendy J Ungar; David Fox
Journal:  Med Decis Making       Date:  2014-08-21       Impact factor: 2.583

2.  Obtaining a genetic diagnosis in a child with disability: impact on parental quality of life.

Authors:  M Lingen; L Albers; M Borchers; S Haass; J Gärtner; S Schröder; L Goldbeck; R von Kries; K Brockmann; B Zirn
Journal:  Clin Genet       Date:  2015-07-14       Impact factor: 4.438

3.  Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.

Authors:  Zornitza Stark; Deborah Schofield; Khurshid Alam; William Wilson; Nessie Mupfeki; Ivan Macciocca; Rupendra Shrestha; Susan M White; Clara Gaff
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

4.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

5.  Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.

Authors:  Deborah Schofield; Luke Rynehart; Rupendra Shresthra; Susan M White; Zornitza Stark
Journal:  Genet Med       Date:  2019-05-21       Impact factor: 8.822
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.